Functional modification of agonist-antagonist electromyographic activity for rapid movement inhibition

K Kudo1, T Ohtsuki

  • 1Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Japan.

Insights

This study shows that the ability to stop voluntary arm movements decreases as the time between go and stop signals increases. Muscle activity patterns adapt to modify movement execution and response, suggesting continuous adaptive mechanisms during voluntary actions.

Area of Science:

  • Neuroscience
  • Motor Control
  • Human Movement Science

Background:

  • Voluntary movements require precise motor control.
  • The ability to inhibit or modify ongoing movements is crucial for adapting to changing environments.

Purpose of the Study:

  • To investigate the kinematic and electromyographic (EMG) responses during voluntary elbow extension movements when a stop signal is introduced.
  • To understand how the central nervous system modifies motor commands in response to a late stop signal.

Main Methods:

  • Subjects performed rapid elbow extension movements upon a go signal, with a stop signal presented at varying interstimulus intervals (ISIs).
  • Electromyographic (EMG) activity of biceps brachii and triceps brachii was recorded.
  • Movement kinematics (amplitude, peak velocity) and EMG patterns were analyzed in relation to the timing of the stop signal.

Main Results:

  • Movement inhibition was possible at short ISIs (0 ms) but decreased significantly with longer ISIs (>100 ms).
  • Movement amplitude decreased linearly with increased modification time after the stop signal.
  • EMG patterns showed distinct changes: the initial agonist burst decreased, while the antagonist burst initially increased before decreasing, differing from typical step-tracking movements.

Conclusions:

  • Adaptive mechanisms continuously adjust voluntary motor commands in response to sudden environmental changes, similar to reflex modifications.
  • The observed EMG pattern changes suggest a functional modification of motor responses to effectively stop or alter ongoing movements.
  • These findings highlight the dynamic and adaptive nature of motor control during volitional actions.

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...